OncoSec Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Application with Claims Covering Cytokine-Based Intratumoral Immunotherapies
Stock Information for OncoSec Medical Incorporated
Loading
Please wait while we load your information from QuoteMedia.